-
Taxonomy & unit
-
us-gaap: CNY and USD
-
Description
-
Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.
-
Summary
-
LakeShore Biopharma Co., Ltd. quarterly Liabilities history and growth rate from Q1 2023 to Q1 2024.
- LakeShore Biopharma Co., Ltd. Liabilities for the quarter ending March 31, 2024 was $131M, a 9.35% decline year-over-year.
Liabilities, Quarterly (USD)
Liabilities, YoY Quarterly Growth (%)